Arcadia Biosciences (RKDA) Scheduled to Post Quarterly Earnings on Tuesday

Posted by Micah Haroldson on Nov 5th, 2024

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) will issue its quarterly earnings data after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.77) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). The business had revenue of $1.31 million during the quarter, compared to analysts’ expectations of $0.95 million. Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. During the same period last year, the company earned ($2.64) earnings per share. On average, analysts expect Arcadia Biosciences to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Arcadia Biosciences Price Performance

NASDAQ RKDA traded down $0.06 during trading on Tuesday, reaching $3.85. 2,609 shares of the company’s stock traded hands, compared to its average volume of 18,758. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $5.34. The firm has a market cap of $5.25 million, a price-to-earnings ratio of -0.78 and a beta of 1.27. The company’s 50 day simple moving average is $3.15 and its two-hundred day simple moving average is $2.91.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on RKDA shares. StockNews.com assumed coverage on shares of Arcadia Biosciences in a report on Wednesday, October 30th. They set a “sell” rating on the stock. HC Wainwright reiterated a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Check Out Our Latest Analysis on Arcadia Biosciences

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.